UK biotechs struggling to access finance as scale-up concerns grow
Lacklustre routes to capital mean UK biotechs are struggling to grow as fast as international rivals, according to the British…
Lacklustre routes to capital mean UK biotechs are struggling to grow as fast as international rivals, according to the British…